Elicera Therapeutics AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	17.86	24.85	26.4	29.38	43.82	52.39
Cash & Short-Term Investments	17.86	24.85	26.4	29.38	43.82	52.39
Cash Growth	-60.87%	-5.88%	-10.15%	-32.95%	-16.36%	353.04%
Other Receivables	0.64	0.05	0.88	0.34	0.33	0.2
Total Trade Receivables	0.64	0.05	0.88	0.34	0.33	0.2
Other Current Assets	2.4	2.03	0.28	0.45	1.65	1.62
Total Current Assets	20.9	27.42	27.57	30.17	45.8	54.21
Other Intangible Assets	-	-	-	0.02	0.02	0.04
Long-Term Investments	-	-	0	0	0.48	0.48
Total Assets	20.91	27.42	27.57	30.18	46.31	54.74
Accounts Payable	0.85	2.57	2.04	0.88	0.73	2.05
Accrued Expenses	1.48	1.24	4.4	12.5	12.53	0.31
Other Current Liabilities	0.27	0.25	0.35	0.4	0.24	0.14
Total Current Liabilities	2.6	4.06	6.8	13.77	13.51	2.5
Total Liabilities	2.6	4.06	6.8	13.77	13.51	2.5
Common Stock	2.04	2.04	1.47	0.83	0.83	0.83
Additional Paid-in Capital	21.32	106.06	86.62	61.79	66.79	66.79
Retained Earnings	-5.06	-84.73	-67.33	-51.22	-34.82	-15.38
Shareholders' Equity	18.3	23.36	20.77	16.4	32.8	52.24
Total Liabilities & Equity	20.9	27.42	27.57	30.18	46.31	54.74
Net Cash (Debt)	17.86	24.85	26.4	29.38	43.82	52.39
Net Cash Growth	-28.10%	-5.88%	-10.15%	-32.95%	-16.36%	353.04%
Net Cash Per Share	0.37	0.54	0.84	1.49	1.88	2.93
Book Value	18.3	23.36	20.77	16.4	32.8	52.24
Book Value Per Share	0.38	0.51	0.66	0.83	1.41	2.92
Tangible Book Value	18.3	23.36	20.77	16.38	32.78	52.2
Tangible Book Value Per Share	0.38	0.51	0.66	0.83	1.41	2.92